Sun Pharma deals include the $230 million purchase of US-based dermatology specialist Dusa Pharmaceuticals and $450 million in Israel's Taro Pharmaceutical Industries (Representational Image) Mumbai: Sun Pharmaceuticals Industries, emboldened by ... Deccan Chronicle, 3 weeks ago
1 images for "dusa pharmaceuticals"
Sun Pharmaceuticals Industries, emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the generic drugmaker's strategy said. The just completed ...Financial Chronicle, 3 weeks ago Sun Pharma lines up $7b for M&As Oman Tribune, 3 weeks ago Sun Pharma scouting for more deals; may spend $7bn Economic Times, 3 weeks ago Sun Pharmaceutical may spend $7 bn on M&A Business Today India, 3 weeks ago
: The Medical Science Liaison Society (MSL Society) — the world's first and only non-profit organization dedicated to the advancement of the medical science liaison (MSL) role in the pharmaceutical and other healthcare industries — is proud to ...Carolina Business Connection, 1 week ago
/PRNewswire/ -- This report analyzes the worldwide markets for Energy based Ablation Devices in US$ Million by the following Energy Sources: Electrical, Light, Radiation, Radiofrequency, Ultrasound, and Others. The global market is also analyzed by ...Pettinga Financial Advisors, 2 weeks ago
Dilipbhai, as his friends and industry associates address him, is not much of a social mover and shaker. His only indulgence perhaps is an occasional visit to Matunga — Mumbai's South India — to gorge on sumptuous dosas at the famous Mysore Cafe ...Businessworld India, 3 weeks ago
0 Flares 0 Flares × KISSIMMEE, FLA. (FRONTLINE MEDICAL NEWS) Fractional carbon dioxide laser resurfacing followed by 30 minutes of aminolevulinic acid plus blue light photodynamic therapy cleared 94% of actinic keratoses, significantly ...PM 360, 3 weeks ago
Biofrontera AG ("Biofrontera" or "Company" or "Group) Leverkusen, Germany, 10 April 2015 - Biofrontera AG (FSE/AIM:B8F), the biopharmaceutical company focusing on skin cancer, announces final results for the year ended 31 December 2014. ...TrustNet, 1 month ago
ets are expected to open in the red tracking the SGX Nifty and weak global cues. US markets closed sharply lower led by a sell-off in technology and biotech stocks. The Commerce Department also released a report showing an unexpected drop in ...Stock Markets Review, 1 month ago
MUMBAI: Following the successful closure of the $3.2 billion merger with troubled drug maker Ranbaxy, Dilip Shanghvi-led Sun Pharma said on Wednesday that the company is initiating the integration of the business, which will make the combined entity ...Times of India, 1 month ago
on your WebpageAdd Widget >Get your members hooked!